Joshua Schafer, CCO at ZEVRA THERAPEUTICS, INC. (ZVRA), sold 10,500 shares at $9.19 ($96K) on 2026-02-03, disclosed to the SEC on 2026-02-04.
Scheduled sale ($96k) by CCO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZVRA | BUY | 2023-09-06 | $3K | — | Filing → |
| ZVRA | BUY | 2023-06-30 | $5K | — | Filing → |
| ZVRA | BUY | 2023-03-15 | $9K | — | Filing → |